Literature DB >> 6691416

Redistribution of catecholamines in the ischemic zone of the dog heart.

K H Muntz, H K Hagler, H J Boulas, J T Willerson, L M Buja.   

Abstract

This study evaluated alterations in catecholamines, blood flow, and indices of tissue damage during early myocardial ischemia in the dog. Of the 27 animals studied, the left anterior descending artery was ligated for 1 hour in 11 and for 3 hours in 13, and 3 underwent sham procedures. The severity of ischemia was determined by the radioactive microsphere and thioflavin S techniques. Myocardial catecholamines were measured radioenzymatically, and catecholamine-containing nerve terminals were visualized histochemically and quantitated with the use of a point-counting method. After both 1- and 3-hour occlusions, there was a greater reduction in catecholamine-containing nerve terminals than in total tissue catecholamines in ischemic tissue. In both ischemic and nonischemic tissue, the relative percentages of total catecholamines as norepinephrine, dopamine, and epinephrine were similar. In the dogs with 3-hour occlusions, values (as a percentage of control values) for total tissue catecholamines were 83% in ischemic subepicardium and 76% in ischemic subendocardium, whereas values for catecholamine-containing nerve terminals were 58% and 51%, respectively. (Only the latter three values were significantly different from control values by analysis of variance). Diffusion of catecholamines from the nerve terminals frequently was noted in the ischemic areas, and degenerative changes in nerve terminals were demonstrated by electron microscopy in 2 animals. These data indicate that catecholamines, primarily as norepinephrine, are released from nerve terminals and accumulate in another tissue compartment in the ischemic myocardium. Quantitative light microscopy showed significant myocyte damage after 1 hour of ischemia in the subendocardium, although not in the subepicardium. There was significant damage in the subepicardium and subendocardium after 3 hours of ischemia. Thus, ischemic injury is associated with the redistribution and abnormal localization of catecholamines in ischemic myocardium, and these phenomena occur during the transmural spread of necrosis in evolving myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6691416      PMCID: PMC1900402     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Changes in myocardial composition after coronary artery ligation.

Authors:  R A RUSSELL; J CRAFOORD; A S HARRIS
Journal:  Am J Physiol       Date:  1961-05

2.  An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.

Authors:  G RONA; C I CHAPPEL; T BALAZS; R GAUDRY
Journal:  AMA Arch Pathol       Date:  1959-04

3.  Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat.

Authors:  P B Corr; F X Witkowski; B E Sobel
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

4.  Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

5.  Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation.

Authors:  P A Ebert; R B Vanderbeek; R J Allgood; D C Sabiston
Journal:  Cardiovasc Res       Date:  1970-04       Impact factor: 10.787

6.  Distribution of coronary arterial flow in acute myocardial ischemia.

Authors:  R A Kloner; C E Ganote; K A Reimer; R B Jennings
Journal:  Arch Pathol       Date:  1975-02

7.  Increased alpha-adrenergic receptors in ischemic cat myocardium. A potential mediator of electrophysiological derangements.

Authors:  P B Corr; J A Shayman; J B Kramer; R J Kipnis
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Myocardial and peripheral catecholamine responses to acute coronary artery constriction before and after propranolol treatment in the anaesthetised dog.

Authors:  B P McGrath; S P Lim; L Leversha; A Shanahan
Journal:  Cardiovasc Res       Date:  1981-01       Impact factor: 10.787

9.  Effect of acute coronary artery occlusion on local myocardial extracellular K+ activity in swine.

Authors:  J L Hill; L S Gettes
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

10.  Protective effects of beta-adrenergic blockade in isolated ischemic hearts.

Authors:  L R Bush; D W Haack; M Shlafer; B R Lucchesi
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

View more
  5 in total

Review 1.  The guanine nucleotide-binding regulatory proteins (G proteins) in myocardium with ischemia.

Authors:  M Ohyanagi; T Iwasaki
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Influence of prolonged exercise on myocardial distribution of 123I-MIBG in long-distance runners.

Authors:  M Estorch; R Serra-Grima; I Carrió; A Flotats; A Lizárraga; L L Bernà; T Prats; R Segura
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

3.  Acute myocardial ischaemia in the anaesthetised pig: local catecholamine release and its relation to ventricular fibrillation.

Authors:  F M McDonald; H Knopf; S Hartono; W Polwin; A Bischoff; H Hirche; K Addicks
Journal:  Basic Res Cardiol       Date:  1986 Nov-Dec       Impact factor: 17.165

4.  Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.

Authors:  J A Jackson; J P Reeves; K H Muntz; D Kruk; R A Prough; J T Willerson; L M Buja
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

5.  Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury.

Authors:  K R Chien; A Sen; R Reynolds; A Chang; Y Kim; M D Gunn; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.